|
(116KB)
|
|
What is
the Longitudinal Assessment of Bariatric Surgery
(LABS)? |
The Longitudinal Assessment of Bariatric Surgery
was originally known as the Bariatric Surgery
Clinical Research Consortium. LABS is a National
Institutes of Health (NIH)-funded consortium of
six clinical centers and a data coordinating
center working in cooperation with NIH scientific
staff to plan, develop, and conduct coordinated
clinical, epidemiological, and behavioral
research in bariatric surgery.
|
What is bariatric
surgery? |
Bariatric surgery restricts stomach size
and/or leads to decreased absorption of
nutrients. These procedures can have dramatic
health benefits, such as improved control of
blood sugar or even reversal of type 2
diabetes, but they also carry substantial
risks, including death.
|
How many
people have had bariatric surgery? |
According to the former American Society for
Bariatric Surgery (now the American Society for
Metabolic and Bariatric Surgery, or ASMBS), the
number of procedures increased from about 16,000
in the early 1990s to more than 103,000 in 2003.
The ASMBS estimated that 205,000 people in the
United States would have bariatric surgery in
2007.
|
Why did
the National Institute of Diabetes and Digestive
and Kidney Diseases (NIDDK) launch
LABS?
|
- A majority of U.S. adults are overweight or
obese, with more than 30 percent of adults
considered obese (Body Mass Index, or BMI,
greater than 30). An increasing number of
adults are considered extremely obese (BMI
greater than or equal to 40).
- Numerous studies have shown that behavioral
therapy to improve diet and physical activity
can lead to weight loss of approximately 5 to
10 percent over 4 to 6 months.
- When a person loses weight, obesity-related
conditions such as high blood pressure and type
2 diabetes improve, but if a person regains
weight, these benefits are lost.
- In many cases, a person who regains weight
ends up weighing more than he or she weighed
before the intervention. Doctors need effective
weight-loss methods for people with extreme
obesity and effective ways to maintain
long-term weight loss.
- Currently, the most effective way for
people with extreme obesity to lose substantial
weight and improve their weight-related health
conditions, such as high blood pressure and
type 2 diabetes, is through bariatric
surgery.
- Although an increasing number of persons
with extreme obesity are undergoing bariatric
surgical procedures, there has been little
systematic research to help determine its risks
and benefits or to provide guidance on
appropriate patient selection. To facilitate
research in this area, NIDDK established
LABS.
|
What
is the goal of LABS?
|
LABS has brought together experts in bariatric
surgery, obesity research, internal medicine,
endocrinology, behavioral science, outcomes
research, epidemiology, and other relevant fields
to plan and conduct studies that will analyze the
risks and benefits of bariatric surgery and its
impact on the health and well-being of patients
with extreme obesity, and identify the kinds of
patients who are most likely to benefit.
|
How
will LABS accomplish its goal?
|
The consortium has developed a database for
collecting standardized information on patients
undergoing bariatric surgery at the participating
clinical centers. Rigorously collected
information on patient characteristics, types of
surgery, medical and psychosocial outcomes, and
economic factors will ultimately provide
science-based information on the risks and
benefits of bariatric surgery. This
information should lead to rational
recommendations for clinical care.
LABS is also supporting two clinical studies
that were proposed, designed, and approved by the
Steering Committee (see below). These studies
address:
- The impact of surgical procedures on
insulin resistance and type 2 diabetes.
- The impact of bariatric surgery on rates of
psychopathology, in particular depressive
illness and quality-of-life,
post-operatively.
LABS Centers also collect data and specimens
for future research. These data will provide a
valuable resource for the future study of obesity
and its complications.
|
How
is LABS organized?
|
- Through a competitive, peer-reviewed
process, principal investigators at six
clinical centers and a data coordinating center
were funded in September 2003. These
investigators are listed below.
- The principal investigators at the clinical
centers and data coordinating center and the
NIH project scientist comprise the Steering
Committee, which is the governing body for the
consortium.
- The Steering Committee has met on a
frequent basis to develop the database and plan
the clinical protocols.
- When LABS started, the Steering Committee
members organized working groups to develop the
protocols. The working groups have completed
most of their work, and LABS has established
other subcommittees to address ancillary
studies, adjudication, and publications and
presentations.
- Investigators, scientists, and clinicians
from the participating centers with relevant
expertise participate in the committees and
working groups.
|
What
is the study timeline for LABS?
|
-
LABS was funded in September 2003.
-
During the first 18 months, investigators
worked together to develop the database, plan
the clinical protocols, and obtain
appropriate human subjects approval. The LABS
database started enrolling patients in March
2005.
|
What has LABS accomplished since
it started?
|
LABS is divided into three parts:
-
LABS 1, which evaluates the short-term
safety of bariatric surgery for a period of
30 days.
-
LABS 2, which evaluates longer-term safety
and efficacy of bariatric surgery
(ongoing).
-
LABS 3, which includes detailed
mechanistic studies in the LABS subjects.
LABS 1 started to enroll patients in March
2005. Over 5,000 subjects completed LABS 1
follow-up, which determines adverse outcomes
within the first 30 days after surgery. This
study is complete and the data collected is being
analyzed.
LABS 2 began recruiting patients in February
2006. The goal is to recruit 2,400 patients to
form a detailed description of health problems
before surgery and complications after surgery.
The patients in LABS 2 will be followed up at 6
months, 1 year, and then yearly after surgery.
Researchers will assess multiple areas concerning
surgery, including behavior, diabetes, liver
function, health service delivery, and
economics.
The LABS 3 diabetes study began recruiting
patients in December 2007—and it will
examine the physiological mechanisms that
contribute to improvements of glucose homeostasis
in type 2 diabetes mellitus following gastric
bypass surgery in a subset of LABS 2
subjects.
The LABS 3 psychosocial study began recruiting
patients in April 2007 and includes an in-depth
assessment of current and prior psychopathology
and eating problems in a subset of LABS 2
subjects.
|
What
funds are available for LABS?
|
At the start, LABS was funded at $3 million
per year for 5 years, for a total of $15 million.
There were also opportunities for investigators
to apply for additional funding for ancillary
studies first through a request for applications
(RFA) and currently through a Program
Announcement. Information on Program Announcement
PAR-07-024 is at:
http://grants.nih.gov/grants/guide/pa-files/PAR-07-024.html.
In 2007, an expert panel recommended that
NIDDK extend LABS for an additional 5 years. The
extension will allow researchers to continue data
collection and analysis. A limited-competition
RFA proposal has been issued.
The Office of Research on Women’s Health
(ORWH) provided funds to be used for LABS
research related to women’s health issues.
Information on the ORWH can be found at: http://www4.od.nih.gov/orwh.
|
Will
LABS provide free bariatric surgery for study
participants? |
No. LABS cannot cover the costs of bariatric
surgery or patient care. Study participants must
be able to support the cost of their surgery and
related patient care through medical insurance or
other means. However, any tests or examinations
done solely for research purposes rather than
routine patient care will be done at no cost to
participants.
|
How can
patients get more information about enrollment in
LABS? |
For more information about enrollment in LABS,
see: http://www.niddklabs.org.
|
In
what other ways might LABS help to advance future
obesity research? |
-
LABS may provide the preliminary data
needed for future investigator-initiated
research on bariatric surgery and obesity.
For example, if LABS investigators are able
to identify metabolic and endocrine changes
that take place after bariatric surgery, this
information would allow researchers to submit
independent applications for full-scale
clinical studies.
-
LABS may encourage researchers to study
the causes and treatments of obesity and its
related health problems by providing access
to laboratory specimens and tissues.
-
The presence of coordinated obesity
research efforts at participating
institutions may provide opportunities for
research and clinical training to students in
the health professions, as well as to young
investigators.
-
Information on the types of data being
collected in the LABS database (not
individual patient information) will be
available on the LABS website, so that other
interested clinicians and researchers can
collect similar data on their patients,
facilitating additional research on bariatric
surgery. See
http://www.edc.pitt.edu/labs/Public/LABS-1DescriptionPaper/.
|
LABS
Principal Investigators at the Six Clinical
Centers |
Paul D. Berk, M.D.
Professor of Medicine
Columbia University
Medical Center
630 West 168th Street
P.O. Box 83 BB912
New York, NY 10029–6574
Anita P. Courcoulas, M.D.
Director, Minimally Invasive Bariatric and
General Surgery
University of Pittsburgh Medical Center
Division of Thoracic and Foregut Surgery
5200 Centre Avenue, Suite 715
Pittsburgh, PA 15232
David R. Flum, M.D., M.P.H., FACS
University of Washington
1950 NE Pacific Street
P.O. Box 356410
Seattle, WA 98195–6410
James E. Mitchell, M.D.
University of North Dakota
Neuropsychiatric Research Institute
120 8th Street South, 2nd Floor
P.O. Box 1415
Fargo, ND 58107
Walter J. Pories, M.D., FACS
Professor of Surgery and Biochemistry
Brody School of Medicine
East Carolina University
600 Moye Boulevard
Greenville, NC 27858
Bruce M. Wolfe, M.D.
Oregon Health and Science University
Division of General Surgery—BTE223
3181 S.W. Sam Jackson Park Road
Portland, OR 97239–3098
|
Data Coordinating
Center
|
Steven H. Belle, Ph.D., MScHyg
Professor of Epidemiology and Biostatistics
Data Coordinating Center
University of Pittsburgh
504 Parran Hall
130 Desoto Street
Pittsburgh, PA 15261
|
NIDDK
Project Scientist |
Carolyn W. Miles, Ph.D.
Director, Clinical Obesity and Nutrition
Program
Division of Digestive Diseases and Nutrition
NIDDK
NIH
6707 Democracy Boulevard
Room 665, MSC 5450
Bethesda, MD 20892–5450
|
For Further
Information |
For additional assistance with media queries,
including a list of LABS investigators with
specific expertise in topics related to bariatric
surgery, contact: Ms. Leslie L. Curtis, M.A.
(301) 496–3585, NIDDK Office of
Communications and Public Liaison, (301)
496–3583, curtisl@extra.niddk.nih.gov. For
more information about LABS, see: http://www.niddklabs.org.
For general information about
bariatric surgery, obesity, and related topics,
contact:
The Weight-control Information Network
(WIN)
1 WIN Way
Bethesda, MD 20892–3665
Phone: (202) 828–1025; Toll-free:
1–877–946–4627
http://www.win.niddk.nih.gov
The National Heart, Lung, and Blood Institute
Information Center
P.O. Box 30105
Bethesda, MD 20824–0105
Phone: 1–800–575–9355
http://www.nhlbi.nih.gov
For information about obesity research
at NIH, see:
NIH Obesity Research
http://www.obesityresearch.nih.gov
American Society for Metabolic and Bariatric Surgery
http://www.asmbs.org
(This site is not affiliated with
NIH.)
|
|
Weight-control Information Network
1 WIN Way
Bethesda, MD 20892–3665
Phone: (202) 828–1025
Toll-free number:
1–877–946–4627
Fax: (202) 828–1028
Email: win@info.niddk.nih.gov
Internet: http://www.win.niddk.nih.gov
The Weight-control Information Network (WIN)
is a service of the National Institute of
Diabetes and Digestive and Kidney Diseases
(NIDDK) of the National Institutes of Health,
which is the Federal Government’s lead
agency responsible for biomedical research on
nutrition and obesity. Authorized by Congress
(Public Law 103–43), WIN provides the
general public, health professionals, the media,
and Congress with up-to-date, science-based
health information on weight control, obesity,
physical activity, and related nutritional
issues.
Publications produced by WIN are reviewed by
both NIDDK scientists and outside experts.
This publication is not copyrighted. WIN
encourages users of this brochure to duplicate
and distribute as many copies as desired.
|
|
NIH Publication No. 04–5573
November 2008
The National Institute of Diabetes and
Digestive and Kidney Diseases is part of the
National Institutes of Health, under the U.S.
Department of Health and Human Services.
|
|
|